“…Our team of multi-disciplinary clinicians (HIJ, JK,öO, NR, BR) meticulously ensured the compliance of these criteria for every included SCD participants prior to classifying them as such. Prodromal AD patients had to fulfill the latest research criteria proposed by Albert et al [36], Dubois et al [37,38], and Petersen [39]: self-reported memory complaints or informed by a knowledgeable caregiver (verified during the anamnesis or using the cut-off value of ≥25 on the MAC-Q) [32] along with objective cognitive deficits (corrected for age, gender, and education) of at least 1.5 SD from the normative mean [39,40], a mini mental status examination score of ≥23 [41], and, most important, evidence of biomarkers, i.e., cerebrospinal fluid tau/A 42 ratio of >0.52 [42], medial temporal lobe atrophy score ≥3 using MR imaging [43], or typical temporoparietal hypometabolism on fluorodeoxyglucose positron emission tomography (FDG-PET) imaging [36,44], but preserved activities of daily living (confirmed by a clinician during the anamnesis or by the Bayer Activities of Daily Living Scale cut-off of >5) [45]. This combination of evidence ensures the selection of patients that have the highest probability of converting to AD and are thus considered prodromal AD patients [37,38].…”